PL1514871T3 - Dispiro 1,2,4 – trioksolanowe środki przeciwmalaryczne - Google Patents

Dispiro 1,2,4 – trioksolanowe środki przeciwmalaryczne

Info

Publication number
PL1514871T3
PL1514871T3 PL04254821T PL04254821T PL1514871T3 PL 1514871 T3 PL1514871 T3 PL 1514871T3 PL 04254821 T PL04254821 T PL 04254821T PL 04254821 T PL04254821 T PL 04254821T PL 1514871 T3 PL1514871 T3 PL 1514871T3
Authority
PL
Poland
Prior art keywords
dispiro
trioxolane antimalarials
trioxolane
antimalarials
Prior art date
Application number
PL04254821T
Other languages
English (en)
Inventor
Jonathan L Vennerstrom
Yuanquing Tang
Yuxiang Dong
Hughes Matile
William N Charman
Jaques Chollet
Maniyan Padmanilayam
Kumar Yatendra
Chand Yadav Gyan
Original Assignee
Medicines For Malaria Venture Mmv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicines For Malaria Venture Mmv filed Critical Medicines For Malaria Venture Mmv
Publication of PL1514871T3 publication Critical patent/PL1514871T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4747—Quinolines; Isoquinolines spiro-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D323/00—Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
    • C07D323/02—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL04254821T 2003-08-18 2004-08-11 Dispiro 1,2,4 – trioksolanowe środki przeciwmalaryczne PL1514871T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/642,721 US6825230B2 (en) 2002-06-21 2003-08-18 Spiro and dispiro 1,2,4-trixolane antimalarials
EP04254821.4A EP1514871B1 (en) 2003-08-18 2004-08-11 Dispiro 1,2,4 - trioxolane antimalarials

Publications (1)

Publication Number Publication Date
PL1514871T3 true PL1514871T3 (pl) 2016-05-31

Family

ID=31888549

Family Applications (2)

Application Number Title Priority Date Filing Date
PL04254821T PL1514871T3 (pl) 2003-08-18 2004-08-11 Dispiro 1,2,4 – trioksolanowe środki przeciwmalaryczne
PL369644A PL227294B1 (pl) 2003-08-18 2004-08-18 Spiro-lub dispiro-1,2,4-trioksolan, kompozycja farmaceutyczna zawierajaca ten zwiazek i zastosowanie zwiazku

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL369644A PL227294B1 (pl) 2003-08-18 2004-08-18 Spiro-lub dispiro-1,2,4-trioksolan, kompozycja farmaceutyczna zawierajaca ten zwiazek i zastosowanie zwiazku

Country Status (16)

Country Link
US (1) US6825230B2 (pl)
EP (2) EP2599779A1 (pl)
JP (1) JP2005060396A (pl)
KR (1) KR20050020946A (pl)
CN (1) CN1626530A (pl)
AU (1) AU2004203864B2 (pl)
CA (1) CA2478146C (pl)
CY (1) CY1117133T1 (pl)
DK (1) DK1514871T3 (pl)
ES (1) ES2560080T3 (pl)
HU (1) HUE028313T2 (pl)
MX (1) MXPA04008022A (pl)
PL (2) PL1514871T3 (pl)
PT (1) PT1514871E (pl)
SG (2) SG109559A1 (pl)
SI (1) SI1514871T1 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7371778B2 (en) * 2002-06-21 2008-05-13 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials
US20080125441A1 (en) * 2002-06-21 2008-05-29 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials
US6825230B2 (en) * 2002-06-21 2004-11-30 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trixolane antimalarials
WO2006010362A1 (de) * 2004-07-23 2006-02-02 Justus-Liebig-Universität Giessen Aminoadamantan-derivate, verfahren zu ihrer herstellung und ihre verwendung
GB0421911D0 (en) * 2004-10-01 2004-11-03 Univ Cambridge Tech Methods and means
US8067620B2 (en) * 2005-05-04 2011-11-29 Medicines For Malaria Venture Mmv Dispiro 1,2,4-trioxolane antimalarials
WO2006123314A2 (en) * 2005-05-18 2006-11-23 Ranbaxy Laboratories Limited Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials
CN101472582A (zh) * 2006-05-17 2009-07-01 兰贝克赛实验室有限公司 联用合成青蒿素衍生物和双喹啉衍生物的抗疟疗法
DK2029569T3 (da) * 2006-05-24 2013-02-11 Ranbaxy Lab Ltd Fremgangsmåde til fremstillingen af dispiro-1,2,4-trioxolan-antimalariamidler (oz277 salte)
FR2924343A1 (fr) * 2007-12-04 2009-06-05 Palumed Sa Nouvelles utilisations therapeutiques de molecules duales contenant un derive peroxydique.
WO2010001824A1 (ja) 2008-07-01 2010-01-07 国立大学法人 岡山大学 新規抗住血吸虫剤
AP2946A (en) * 2009-04-17 2014-07-31 Ranbaxy Lab Ltd A process for the preparation of 1, 2, 4-trioxolane antimalarials
AP2014007413A0 (en) 2011-07-14 2014-02-28 Ranbaxy Lab Ltd Stable dosage forms of arterolane and piperaquine
US10287312B2 (en) 2014-02-14 2019-05-14 The Regents Of The University Of California Cyclic peroxides as prodrugs for selective delivery of agents
WO2019005977A1 (en) 2017-06-27 2019-01-03 The Regents Of The University Of California Trioxolane agents
EP4574143A1 (en) 2023-12-21 2025-06-25 Universität Regensburg Inhibitors of plasmodia remodeling enzymes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6486199B1 (en) * 2001-06-21 2002-11-26 Medicines For Malaria Venture Mmv International Centre Cointrin Spiro and dispiro 1,2,4-trioxolane antimalarials
US6825230B2 (en) * 2002-06-21 2004-11-30 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trixolane antimalarials

Also Published As

Publication number Publication date
DK1514871T3 (en) 2016-01-25
CA2478146C (en) 2009-02-03
AU2004203864A1 (en) 2005-03-10
PT1514871E (pt) 2016-02-08
SG139752A1 (en) 2008-02-29
SI1514871T1 (sl) 2016-02-29
AU2004203864B2 (en) 2007-06-07
US6825230B2 (en) 2004-11-30
KR20050020946A (ko) 2005-03-04
PL369644A1 (pl) 2005-02-21
SG109559A1 (en) 2005-03-30
US20040039008A1 (en) 2004-02-26
JP2005060396A (ja) 2005-03-10
HUE028313T2 (en) 2016-12-28
ES2560080T3 (es) 2016-02-17
MXPA04008022A (es) 2005-06-08
CN1626530A (zh) 2005-06-15
EP1514871A1 (en) 2005-03-16
AU2004203864B9 (en) 2005-03-10
CY1117133T1 (el) 2017-04-05
PL227294B1 (pl) 2017-11-30
EP2599779A1 (en) 2013-06-05
CA2478146A1 (en) 2006-02-17
EP1514871B1 (en) 2015-10-21

Similar Documents

Publication Publication Date Title
MX267068B (es) Derivados simetricos de triazina.
EG25273A (en) Substituted dihydroquinazolines.
ZA200606974B (en) Substituted 1,2,3,4-tetrahydrolsoquinoline derivatives
PT1514871E (pt) Diespiro 1,2,4-trioxolanos contra a malária
ZA200506744B (en) PyrazoloÄ1,5-AÜpyrimidine derivatives
EP1830858A4 (en) 3,6-BICYCLOLIDE
AP2006003588A0 (en) Compounds artemisinin.
GB0425572D0 (en) 1,7-Naphthyridines
IL173884A0 (en) Cycloalkylaminoacid compounds, processes for making and uses thereof
EP1723125A4 (en) 1,2,4-benzotriazine-1,4-dioxides
LU91022B1 (en) Sektionaltor.
ZA200702193B (en) 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
GB0316852D0 (en) Compounds, inks and processes
GB0316854D0 (en) Compounds,inks and processes
TJ391B (en) Medicinal-preventive biopreparation subtilben.
GB0320813D0 (en) W.R.M et al
GB0316855D0 (en) Inks, compounds and processes
GB0317414D0 (en) Compounds, inks and processes
GB0316358D0 (en) New uses
GB0315782D0 (en) Uses
GB0315839D0 (en) www.wereuthe1.com
HU0300672D0 (en) Aerodyne
GB0314407D0 (en) The memopage
GB0301484D0 (en) The clubey
GB0306818D0 (en) The slumber-bumper